BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4048943)

  • 21. Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hirose Y; Ohnishi M; Mori H
    Carcinogenesis; 1996 Feb; 17(2):369-72. PubMed ID: 8625465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils.
    Howard TH; Meyer WH
    J Cell Biol; 1984 Apr; 98(4):1265-71. PubMed ID: 6232281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ornithine decarboxylase, mitogen-activated protein kinase and matrix metalloproteinase-2 expressions in human colon tumors.
    Nemoto T; Kubota S; Ishida H; Murata N; Hashimoto D
    World J Gastroenterol; 2005 May; 11(20):3065-9. PubMed ID: 15918191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of timing of administration and dose of difluoromethylornithine on rat colonic carcinogenesis.
    Luk GD; Zhang SZ; Hamilton SR
    J Natl Cancer Inst; 1989 Mar; 81(6):421-7. PubMed ID: 2493096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
    Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 counteracts the inhibition by indomethacin of rat colon ornithine decarboxylase induction by deoxycholic acid.
    Narisawa T; Hosaka S; Niwa M
    Jpn J Cancer Res; 1985 May; 76(5):338-44. PubMed ID: 3924707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention by amiloride of experimental carcinogenesis in rat colon induced by azoxymethane.
    Tatsuta M; Iishi H; Baba M; Uehara H; Nakaizumi A
    Carcinogenesis; 1995 Apr; 16(4):941-2. PubMed ID: 7728977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple promoter elements govern expression of the human ornithine decarboxylase gene in colon carcinoma cells.
    Moshier JA; Osborne DL; Skunca M; Dosescu J; Gilbert JD; Fitzgerald MC; Polidori G; Wagner RL; Friezner Degen SJ; Luk GD
    Nucleic Acids Res; 1992 May; 20(10):2581-90. PubMed ID: 1598217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-adenosylmethionine decarboxylase activity and utilization of exogenous putrescine are enhanced in colon cancer cells stimulated to grow by EGF.
    Milovic V; Turhanowa L; Fares FA; Lerner A; Caspary WF; Stein J
    Z Gastroenterol; 1998 Nov; 36(11):947-54. PubMed ID: 9880821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
    Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H
    Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in expression of oncogenes and endogenous retroviral-like sequences during colon carcinogenesis.
    Guillem JG; Hsieh LL; O'Toole KM; Forde KA; LoGerfo P; Weinstein IB
    Cancer Res; 1988 Jul; 48(14):3964-71. PubMed ID: 3383191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of beta-carotene supplementation on indices of colonic cell proliferation.
    Frommel TO; Mobarhan S; Doria M; Halline AG; Luk GD; Bowen PE; Candel A; Liao Y
    J Natl Cancer Inst; 1995 Dec; 87(23):1781-7. PubMed ID: 7473835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA.
    Izant JG; Weintraub H
    Science; 1985 Jul; 229(4711):345-52. PubMed ID: 2990048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From colonic polyps to colon cancer: pathophysiology, clinical presentation, screening and colonoscopic therapy.
    Cappell MS
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):351-73. PubMed ID: 18043553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood polyamine levels after oral ornithine load, a diagnostic marker of hyperproliferative premalignant and malignant stages in a model of colon carcinogenesis.
    Schleiffer R; Duranton B; Gossé F; Hasselmann M; Raul F
    Cancer Detect Prev; 2000; 24(6):542-8. PubMed ID: 11198268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of a low protein diet on the response of rat colonic and hepatic ornithine decarboxylase activity to sodium deoxycholate and thioacetamide treatment.
    Siegler JM; Kazarinoff MN
    J Nutr; 1984 Mar; 114(3):574-80. PubMed ID: 6699738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early induction of rat colonic epithelial ornithine and S-adenosyl-L-methionine decarboxylase activities by N-methyl-N'-nitro-N-nitrosoguanidine or bile salts.
    Takano S; Matsushima M; Ertürk E; Bryan GT
    Cancer Res; 1981 Feb; 41(2):624-8. PubMed ID: 7448810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sources of variability in estimating ornithine decarboxylase activity and polyamine contents in human colorectal mucosa.
    Hixson LJ; Emerson SS; Shassetz LR; Gerner EW
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):317-23. PubMed ID: 8061580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colon cancer screening may change with DNA test.
    Mayo Clin Health Lett; 2001 Feb; 19(2):4. PubMed ID: 11216032
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemoprevention of colon cancer by dietary curcumin.
    Rao CV; Rivenson A; Simi B; Reddy BS
    Ann N Y Acad Sci; 1995 Sep; 768():201-4. PubMed ID: 8526348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.